Jonathan Allan
GENERAL COUNSEL & CORP SEC · 3 filings · Latest: Mar 20, 2026
Stoke Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
STOK | Jonathan Allan | GENERAL COUNSEL & CORP SEC | Mar 20, 2026 | Sale | $33.69 | 9,293 | $313.0K | 19,543 | |
STOK | Jonathan Allan | GENERAL COUNSEL & CORP SEC | Mar 18, 2026 | Sale | $31.34 | 4,628 | $145.1K | 28,836 | |
STOK | Jonathan Allan | GENERAL COUNSEL & CORP SEC | Mar 17, 2026 | Sale | $33.01 | 4,267 | $140.8K | 33,464 | |
STOK | Jonathan Allan | GENERAL COUNSEL & CORP SEC | Mar 15, 2026 | Option Exercise | $0.00 | 25,475 | — | 37,731 |